 |
|
TOPAZ RESEARCH & DEVELOPMENT |
 |
The Pipeline to ProgressTopaz Pharmaceuticals Research and DevelopmentGiven that ivermectin shares a history of use in animals and humans, relative to its currently approved indications, it's not surprising that Topaz Pharmaceuticals has chosen this compound as the core of its research and development program. Topaz Pharmaceuticals has assembled a team of world-class scientific advisors and researchers who share a history of experience with ivermectin use across the globe. Much of the research being developed to support our regulatory application to use ivermectin as a novel head lice therapy is based on the findings and patents received by Dr. Craig Burkhart. Now that Topaz Pharmaceuticals has completed its Phase 1 and Phase 2 trials, pivotal Phase 3 trials are expected to begin soon. To find out more about our research and development program, contact us. See who supports us here. |
|